Stock Market Today: S&P 500, Dow Futures Down Ahead Of ''Triple Witching'' As Iran Warns Of ''Zero Restraint''—FedEx, Super Micro Computer In Focus (news.google.com)
Lilly''s triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes (news.google.com)
Disney CEO Changeover: Josh D’Amaro Says Disney Will Be ‘Digital Centerpiece’ for Growth as Bob Iger Delivers Farewell Address: ‘It Has Meant More to Me Than I Can Say’ (news.google.com)
FDA approval of ICOTYDE (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide (news.google.com)